Remarkably, the only report that revealed LAG-3 expression in pediatric cHL exhibited worse event-free survival (EFS) but in patients with the lowest density of LAG-3 expression in contrast to those with the highest density of expression that exhibited better survival (26). Here, LAG3 is linked to classic Hodgkin lymphoma.